RSC Publishing is delighted to announce the appointment of Professor Bingcheng Lin and Professor Abraham Lee as new members of the Lab on a Chip Editorial Board. 

Bingcheng Lin is Professor of the Dalian Institute of Chemical Physics, Chinese Academy of Sciences. He received his Ph.D in Chemistry from the Chinese Academy of Sciences. In the 1990s, his research interests included capillary electrophoresis and its applications in life science. More recently, his research has focused on the development of 

microfluidic-based technologies for biomedical applications with an emphasis on medical diagnostics and drug screening. Professor Lin is the author or co-author of more than 260 peer-reviewed scientific articles, 60 patents and 7 books,including 2 books on "Lab on Chip" published by Sciences Press, China, in 2006 and 2008 respectively. Prof. Lin won the local first prize of national science on capillary electrophoresis (2002), and first prize of technological invention on lab-on-chip (2007). He is also the chair of Capillary Electrophoresis Committee in China. 

Abraham (Abe) P. Lee is Professor in the Departments of Biomedical Engineering (BME) and Mechanical and Aerospace Engineering (MAE) at the University of California at Irvine in the USA. He also serves as the director of the Micro/nano Fluidics Fundamentals Focus (MF3) Center. Dr. Lee started his career at Lawrence Livermore National Laboratory and led projects on the development of microtools for the treatment of stroke and biowarfare defense. Dr. Lee received his Ph.D. degree in Mechanical Engineering from the University of California at Berkeley. Over his career, he has developed a

series of LOC devices for biomedical and biotechnological applications. His current research is focused on the development of micro electrofluidics and droplet microfluidic platforms for the following applications: biosensors to detect environmental and terrorism threats, point-of-care diagnostics, "smart" nanomedicine for early detection and treatment, automated cell sorting technologies, and tissue engineering and cell-based therapeutics.